Henry Meds Review (2026): Compounded GLP-1 Pricing, Pros, Cons, Alternatives

Key takeaways

Henry Meds is the trade name of Adonis Health, Inc., a cash-pay telehealth platform whose clinicians belong to independent medical groups. On October 10, 2026 its weight program listed only compounded GLP-1s (injectable semaglutide and liraglutide, dissolving or sublingual semaglutide, dissolving tirzepatide tablets, lower-dose 'microdose' plans) plus phentermine. No brand GLP-1, no insurance.
Henry says GLP-1 care starts at $179 a month with visits, medication, supplies and shipping included. Its price list, last updated December 3, 2025, shows injectable semaglutide at $297 a month or $2,364 for a year paid in full, liraglutide at $179 a month and dissolving tirzepatide at $1,047 for a three-month supply.
Henry does not name its pharmacies. Its product pages say a 503A pharmacy or a 503B outsourcing facility; its terms say 503A. Tirzepatide is offered only as a compounded tablet dissolved in the mouth, a form no published human trial has tested.
We found no FDA warning letter to Henry Meds or Adonis Health on October 10, 2026, including among the 55 telehealth letters of 2026.
Trustpilot showed 4.4 out of 5 from 12,535 reviews. Leaving a multi-month plan early can mean paying the balance unless a clinician finds a medical reason, and shipped medication is final sale.

Disclosure. The Peptide Doctrine is an independent editorial project. It currently has no sponsor and runs no advertising: we accept no payment for reviews, rankings or placements, we run no affiliate links, and we do not sell or link to "research-use" peptide vendors. Content is educational and is not medical advice.

Henry Meds at a glance

Facts as published on Henry's own pages and read on October 10, 2026, unless another source is named. The full price arithmetic is in our Henry Meds cost breakdown.

	What we found
Company	Adonis Health, Inc., a Delaware corporation doing business as Henry Meds; a platform that does not employ clinicians or fill prescriptions itself
Main products	Compounded semaglutide (weekly injection, dissolving tablet or sublingual drops), liraglutide (daily injection) and tirzepatide (dissolving tablet); microdose plans; phentermine; testosterone; women's hormone therapy; ED
Pricing model	One bundled price covering provider visits, medication, supplies, shipping and follow-up; monthly plans, plus 6- and 12-month plans for some drugs, cheaper if paid in full
Sample prices	GLP-1 'starts at $179/month'; injectable semaglutide $297 a month, $1,482 for 6 months or $2,364 for 12 months paid in full; liraglutide $179 a month; dissolving tirzepatide $1,047 for a three-month supply ($891 paid in full)
States served	'States we support'; no list on the pages we read; GLP-1 care for ages 18 to 70
Clinician model	Video visit, or in some states a provider review without video; portal messaging; free evaluation of up to 15 minutes
Pharmacy named	No. Product pages: a 503A pharmacy or a 503B outsourcing facility; terms: prepared under section 503A
Labs	Ordered by the provider when needed, through Quest or an at-home kit; included in testosterone pricing; no requirement stated for GLP-1s
Insurance	None; self-pay only, no Medicare or Medicaid; HSA or FSA use not guaranteed
Cancellation	Online, by email or by phone; multi-month plans may have to be paid out unless a provider finds a medical reason; shipped medication is final sale
FDA warning letters	None found on October 10, 2026
Ratings (October 10, 2026)	Trustpilot 4.4 of 5 from 12,535 reviews; BBB profile could not be loaded

How we reviewed Henry Meds

On October 10, 2026 we read Henry's home, FAQ and product pages, its program price list, terms of service (last updated August 6, 2026), refund policy and medication safety page; searched FDA's warning-letter database and the 2026 telehealth letter batches for every name the company uses; and read Henry's Trustpilot profile. The Better Business Bureau blocked our requests.

We did not sign up, pay or take a consultation, so nothing here describes a customer experience, and we quote no individual reviews. We did not contact Henry before publication, and no company paid for or previewed this page. Corrections go to editors@peptidedoctrine.com.

What Henry Meds offers

Compounded GLP-1s in several forms. Henry lists compounded semaglutide as a weekly injection, compounded liraglutide as a daily injection, and two non-injectable lines: semaglutide as a mint-flavored tablet that dissolves in the mouth or as drops under the tongue, and tirzepatide as a daily dissolving tablet (Henry GLP-1 pages). 'Microdose' plans sell the same compounded semaglutide at lower doses; our microdosing explainer covers what is known about doses below the label's. We found no injectable tirzepatide and no brand GLP-1, such as Wegovy or Zepbound. The drugs are covered in our compounded semaglutide and compounded tirzepatide hubs.

Other programs. Phentermine at $149 a month, testosterone therapy from $129 a month with labs, women's hormone therapy from $149 a month, and erectile dysfunction treatment (Henry program pricing). Henry offers no sermorelin, NAD+ or other peptide.

What the evidence covers. Semaglutide's weight-loss figures come from trials of the approved products; in STEP 1, adults without diabetes lost an average of 14.9 percent of body weight over 68 weeks on weekly 2.4 mg injections, against 2.4 percent on placebo (Wilding 2021). A PubMed search we ran on October 10, 2026 found no published human trial of sublingual or mouth-dissolving semaglutide or tirzepatide for weight loss. A review of compounded GLP-1 products that differ from the approved ones found all 17 single-ingredient products were sublingual or orally disintegrating, and that any advantage over the approved oral tablets has not been shown (Belcourt 2026). Henry's own pages say compounded drugs may differ in efficacy and safety and that trial data on approved drugs should not be used to judge them (Henry GLP-1 pages).

Pricing in brief

Henry's GLP-1 pages say treatment 'starts at $179/month', covering visits, medication, supplies and support (Henry GLP-1 pages), and its terms point to a program price list as the comprehensive list of prices (Henry terms). That list, last updated December 3, 2025, prices injectable semaglutide at $297 a month (about $197 a month on a year paid in full), liraglutide and sublingual semaglutide at $179 a month, dissolving semaglutide tablets at $249, and dissolving tirzepatide at $1,047 for a three-month supply (Henry program pricing). Our cost breakdown has every plan and the first-year totals.

The list has gaps. It does not show how price changes with dose, although the GLP-1 pages say price varies by dosing; the tirzepatide entry is headed a three-month supply but describes delivery over six months; and the quantities on the monthly semaglutide plan, up to 10 mg every 70 days or 12.5 mg every 90 days, average about 1 mg a week, below the 2.4 mg maintenance dose on the Wegovy label (Wegovy label). Ask for the price at the dose you are likely to reach, in writing.

Clinicians, visits and labs

Henry describes itself as a platform that handles scheduling, billing, technology and support, while licensed clinicians in an independent contracted medical group make the prescribing decisions (Henry terms). After a medical form of about five minutes, you book a video visit or, depending on your state, choose a provider review without video; messages go through the patient portal (Henry FAQ). The first evaluation is free and lasts up to 15 minutes; if a prescription is written, you are enrolled in a subscription and charged immediately (Henry terms). GLP-1 treatment is limited to adults aged 18 to 70 (Henry GLP-1 pages).

Labs are ordered when a provider decides they are needed, through Quest or an at-home collection kit, with the cost included in the plan (Henry terms). The GLP-1 pages state no lab requirement, which is common in weight-loss telehealth; our complete guide to peptide therapy sets out what a full evaluation usually includes. Most patients receive medication 8 to 10 business days after the visit, and California orders can take longer because of extra testing requirements for compounded drugs (Henry GLP-1 pages).

Where the medication comes from

Henry says it works only with licensed US compounding pharmacies but does not name them. Its product pages say each compounded GLP-1 is made in a 503A compounding pharmacy or a 503B outsourcing facility (Henry GLP-1 pages), while its terms say compounded medications are prepared under section 503A. The terms let prescriptions move between affiliated pharmacies and say some partners may share ownership with Henry's stakeholders, without naming them (Henry terms).

Two consequences. A different pharmacy can mean a different vial concentration, so check every label against the dose with our units converter or peptide calculator. And the 503B question matters in 2026: outsourcing facilities have had no basis to compound semaglutide or tirzepatide from bulk drug substance since the shortages ended, and FDA proposed in May 2026 to keep both, and liraglutide, off the 503B list (Federal Register, May 2026). Ask which pharmacy will fill your order and under which section.

Cancellation, refunds and the fine print

Leaving a multi-month plan early. Henry's FAQ says you can cancel any time, but that on a multi-month plan you may have to pay the rest of the balance unless a provider finds a medical reason you cannot continue; the same FAQ promises 'no long-term contracts' (Henry FAQ). The refund policy allows a prorated refund of prepaid fees when a licensed clinician documents that therapy is contraindicated and Henry's clinical team agrees; dispensed medication is excluded (Henry refund policy).
How to cancel. Online, by email or by phone, at least 48 hours before the term ends; cancellation takes effect at the end of the paid period, with no refunds for partly used periods unless the law requires them (Henry terms).
Medication is final sale. Damage or a suspected temperature problem must be reported within 48 hours of delivery, and the remedy is a replacement. For each evaluation that results in a prescription, $30 of the bundled charge is a non-refundable consultation fee, and a processing fee may be deducted from any refund (Henry refund policy).
Disputes. Individual arbitration with a class-action waiver, unless you opt out in writing within 30 days of first accepting the terms (Henry terms).

FDA, the courts and the 2026 legal picture

No warning letter found. On October 10, 2026 a search of FDA's warning-letter database for Henry Meds, Henry, Adonis and Adonis Health returned no letter addressed to the company. Neither name is among the recipients of the 30 telehealth letters dated February 20, 2026 (announced March 3) or the 25 dated June 8, 2026 (posted June 16), nor in any other letter in the database that mentions semaglutide, tirzepatide, liraglutide or telehealth (FDA database search).

One phrase to watch. Henry's FAQ says compounded medications are 'not FDA-approved in the same way as commercial drugs' but 'do use FDA-approved ingredients' (Henry FAQ). Compounded drugs are not FDA-approved in any way. In a June 8, 2026 warning letter to another telehealth company, FDA cited a claim that its treatments used FDA-approved active ingredients as a representation that compounded products had been approved or evaluated when they had not (FDA, June 2026). FDA has made no such finding about Henry, and Henry's product pages state plainly that compounded medications do not go through FDA approval.

How the compounded program fits the rules. Since the shortages ended, compounded semaglutide and tirzepatide are lawful only when a licensed 503A pharmacy prepares them for a named patient whose prescriber documents a clinically significant difference from the approved drug; price is not such a reason, as our tracker and legal explainer set out, and the tracker applies the same principle to liraglutide. Henry's terms describe compounded drugs as formulations for a patient's specific needs when an approved product is not available or not appropriate (Henry terms). Whether a prescription meets the test depends on the reason written on it; FDA's September 2026 letter to a large compounding pharmacy said reasons picked from a telehealth platform's menu undermine the individual judgment the law requires (Frier Levitt 2026). We found no FDA or court finding about Henry's prescriptions. Ask your prescriber what reason is on yours.

Ratings

On October 10, 2026 Trustpilot showed 4.4 out of 5 from 12,535 reviews, 84 percent five-star and 7 percent one-star, with 464 reviews in the previous 12 months; it noted that Henry claimed the profile in April 2022, pays for a Trustpilot subscription and invites its customers to review (Trustpilot). The BBB site blocked our requests, so we report no BBB rating or complaint count. Star averages measure satisfaction with service, not the quality or legality of a medication.

What Henry's outcome claim rests on

Henry's GLP-1 pages say people taking injectable semaglutide with Henry lost about 18 percent of their body weight in a year, citing a 2025 retrospective cohort study by Rubio and colleagues in the Journal of Clinical Medical Research (Henry GLP-1 pages). The journal is not indexed in PubMed and the publisher's site refused our request for the full text on October 10, 2026, so we cannot report how many patients it followed, how people who stopped were counted or who funded it. STEP 1 measured its effect against placebo regardless of whether participants stopped treatment; a retrospective analysis of one company's patients may have no comparison group and may count only those who stayed. The claim also appears on the oral and tirzepatide pages, although it describes injectable semaglutide only.

Pros

A public price list and one bundled price that includes visits, medication, supplies and shipping.
A free evaluation, with no charge unless a prescription is written.
Several compounded GLP-1 forms, including non-injectable options, plus phentermine, hormone and ED care on one account.
Online cancellation, a 30-day arbitration opt-out and a prorated refund route when a clinician documents that treatment must stop.
Product pages that state plainly that compounded drugs are not FDA-approved.
No FDA warning letter found as of October 10, 2026.

Cons

Pharmacies not named, and 503A versus 503B described differently on different pages.
No brand GLP-1s and no insurance, Medicare or Medicaid.
Tirzepatide only as a compounded dissolving tablet, a form with no published human trial.
Multi-month plans may have to be paid out if you leave early without a medical reason, despite 'no long-term contracts'.
A price list last updated in December 2025, with no dose-based prices and internal inconsistencies.
An FAQ phrase about FDA-approved ingredients of the kind FDA has objected to, and an outcome claim from a study we could not read.

Who it may suit

Henry fits a cash-paying adult under 70 who wants one bundled price for a compounded GLP-1, is comfortable with injectable semaglutide or liraglutide or with a non-injectable form, and has discussed with the prescriber why a compounded drug rather than the approved one is right for them. It fits less well if you want Wegovy or Zepbound, want to use insurance or Medicare, want to know the pharmacy before paying, want tirzepatide by injection, or want month-to-month flexibility at the lowest price.

Alternatives

Our Henry Meds alternatives guide compares five telehealth services from our directory of online peptide clinics and our Ivim Health review on the same criteria, plus the manufacturer cash programs for brand GLP-1s, which need a prescription but no membership. Brand prices are in our tirzepatide cost guide and peptide therapy cost guide.

Bottom line

Henry Meds is a cash-only telehealth service built around compounded GLP-1s, with a broad menu of forms and a public, bundled price list. Its weak points are disclosure (no named pharmacy, a price list ten months old, inconsistent 503A and 503B language), a tirzepatide offered only in an untested form, and the cost of leaving a long plan early. Before paying, get four things in writing: the total for the whole plan at the dose you are likely to reach, the pharmacy and its 503A or 503B status, the clinical reason for a compounded drug, and the cancellation terms that apply to you.

Frequently asked questions

+Is Henry Meds legit?

It is a real telehealth platform, Adonis Health, Inc. doing business as Henry Meds, whose clinicians belong to independent medical groups and whose compounded drugs come from licensed pharmacies it does not name. On October 10, 2026 we found no FDA warning letter to it, and Trustpilot showed 4.4 out of 5 from 12,535 reviews. Whether a compounded GLP-1 prescription is lawful depends on a documented, patient-specific reason, which you should ask your prescriber to put in writing.

+What is Henry Meds?

A cash-pay telehealth service for weight management, testosterone, women's hormone therapy and erectile dysfunction. Its weight program offers compounded semaglutide, liraglutide and tirzepatide in injectable, dissolving-tablet or sublingual forms, plus phentermine, for one bundled price that includes provider visits, medication, supplies and shipping.

+How much does Henry Meds cost?

Henry says GLP-1 treatment starts at $179 a month. Its price list, last updated December 3, 2025 and read October 10, 2026, shows compounded semaglutide injections at $297 a month or $2,364 for a year paid in full, liraglutide at $179 a month, sublingual semaglutide from $179 a month and dissolving tirzepatide tablets at $1,047 for a three-month supply. Our Henry Meds cost breakdown works out the totals.

+Does Henry Meds take insurance?

No. Henry is self-pay only and does not bill Medicare, Medicaid or other government programs. Its terms say HSA or FSA cards may work in some cases but that eligibility is not guaranteed.

+What pharmacy does Henry Meds use?

Henry does not name its pharmacies. Its product pages say compounded GLP-1s are made in a 503A compounding pharmacy or a 503B outsourcing facility, its terms say compounded drugs are prepared under section 503A, and the terms allow prescriptions to move between affiliated pharmacies. Ask which pharmacy will fill your order before you pay.

+Does Henry Meds prescribe tirzepatide?

Only as compounded tirzepatide tablets that dissolve in the mouth, listed at $1,047 for a three-month supply ($891 paid in full). We found no injectable tirzepatide and no Zepbound or Mounjaro on Henry's pages on October 10, 2026, and no published human trial of dissolving or sublingual tirzepatide.

+How do I cancel Henry Meds?

Through your account online, by email or by phone, at least 48 hours before the current term ends; cancellation takes effect at the end of the period you have paid for. On a multi-month plan Henry's FAQ says you may have to pay the remaining balance unless a provider finds a medical reason you cannot continue.

+Has the FDA sent Henry Meds a warning letter?

Not as of October 10, 2026. A search of FDA's warning-letter database for Henry Meds, Henry, Adonis and Adonis Health returned no letter addressed to the company, and it was not among the recipients of the 55 telehealth warning letters FDA issued in February and June 2026 over compounded GLP-1 marketing.

+What are Henry Meds reviews like?

On October 10, 2026 Trustpilot showed 4.4 out of 5 from 12,535 reviews, 84 percent five-star and 7 percent one-star, and noted that Henry invites its customers to review. The BBB site blocked our requests. Star averages measure satisfaction with service, not the quality or legality of the medication.